Canine adenovirus based rabies vaccines

Developments in Biologicals

Volumn 131, Issue , 2008, Pages 467-476

  Tordo, Noel ^a   Fournier, A ^b   Jallet, C ^a   Szelechowski, M ^b   Klonjkowski, B ^b   Eloit, M ^b  

^a INSTITUT PASTEUR   (France)

^b Healthy Pigs Production and Experimentation Section   (France)

Author keywords

Adenovirus vectors; Cav2; Intramuscular immunisation; Oral vaccine; Rabies

Indexed keywords

DNA VACCINE; GLYCOPROTEIN; RABIES VACCINE; VIRUS ANTIBODY; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL; BLOOD; CONFERENCE PAPER; DOG; DOG DISEASE; GENE VECTOR; GENETICS; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; RABIES; RABIES VIRUS; SERODIAGNOSIS;

ADENOVIRUSES, CANINE; ANIMALS; ANTIBODIES, VIRAL; DOG DISEASES; DOGS; GENETIC VECTORS; GLYCOPROTEINS; INJECTIONS, INTRAMUSCULAR; MICE; NEUTRALIZATION TESTS; RABIES; RABIES VACCINES; RABIES VIRUS; VACCINES, DNA; VIRAL PROTEINS;

EID: 44649176371     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (17)

1. Meslin FX, Fishbein DB, Matter HC: Rationale and prospects for rabies elimination in developing courtries. Curr Top Microbiol Immunol 1994;187:1-26.
2. Belotto A, Leanes LF, Schneider MC, Tamayo H, Correa E: Overview of rabies in the Americas. Virus Res 2005;111:5-12.
3. Pastoret PP, Brochier B: Epidemiology and control of fox rabies in Europe. Vaccine 1999;17:1750-1754.
4. Aubert MF, Masson E, Artois M, Barrat J: Oral wildlife vaccination field trials in Europe, with recent emphasis on France. Curr. Top. Microbiol. Immunol. 1994;187:219-243.
5. Rupprecht CE, Charlton KM, Artois M, Casey GA, Webster WA, Campbell JB, Lawson KF, Schneider LG: Ineffectiveness and comparative pathogenicity of attenuated rabies vaccines for the striped skunk (Mephitis mephitis). J Wildl Dis 1990;26:99-102.
6. Rupprecht CE, Bass L, Smith K, Orciari LA, Niezgoda M, Whitfield SG, Gibbons RV, Guerra M, Hanlon CA: Human infection due to recombinant vaccinia-rabies glycoprotein virus. New Engl J Med 2001; 345:582-586.
7. Marshall E: Gene therapy death prompts review of adenovirus vector. Science. 1999;286:2244-2245.
8. Charlton KM, Artois M, Prevec L, Campbell JB, Casey GA, Wandeler AI, Armstrong J: Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine. Arch Virol 1992; 123:169-179.
9. Appel M, Carmichael LE, Robson DS: Canine adenovirus type 2-induced immunity to two canine adenoviruses in pups with maternal antibody. Am J Vet Res 1975;36,1199-1202.
10. Fischer L, Tronel JP, Pardo-David C, Tanner P, Colombet G, Minke J, Audonnet JC: Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge. Vaccine 2002;20,3485-3497.
11. Baer GM, Brooks RC, Foggin CM: Oral vaccination of dogs fed canine adenovirus in baits. Am J Vet Res 1989;50:836-837.
12. Sumner JW, Shaddock JH, Wu GJ, Baer GM: Oral administration of an attenuated strain of canine adenovirus (type 2) to raccoons, foxes, skunk, and mongoose. Am J Vet Res 1988;49:169-171.
13. Li J, Faber M, Papaneri A, Faber ML, McGettigan JP, Schnell MJ, Dietzschold B: A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice. Virology 2006;356:147-154.
14. Hu RL, Zhang SF, Fooks AR, Yuan HJ, Liu Y, Li HT, Tu C, Xia XZ, Xiao YQ: Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein. Microbes Infect, 2006;8:1090-1097.
15. Hu RL, Liu Y, Zhang SF, Zhang F, Fooks AR: Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies. Vaccine. 2007;25:5301-5307.
16. Fornier-Caruana J, Poirier B, Haond G, Jallet C, Fuchs F, Tordo N, Perrin P: Inactivated rabies vaccine control and release: use of an Elisa method. Biologicals 2003;31:9-16.
17. Desmézières E, Maillard A, Gaudin Y, Tordo N, Perrin P: Differential stability and fusion activity of Lyssavirus glycoprotein trimers. Virus Res 2003;91:181-187.